72 related articles for article (PubMed ID: 7882370)
1. PML nuclear bodies are general targets for inflammation and cell proliferation.
Terris B; Baldin V; Dubois S; Degott C; Flejou JF; Hénin D; Dejean A
Cancer Res; 1995 Apr; 55(7):1590-7. PubMed ID: 7882370
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of promyelocytic leukemia protein and alteration of PML nuclear bodies in early stage of hepatocarcinogenesis.
Yoon GS; Yu E
J Korean Med Sci; 2001 Aug; 16(4):433-8. PubMed ID: 11511788
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues.
Gambacorta M; Flenghi L; Fagioli M; Pileri S; Leoncini L; Bigerna B; Pacini R; Tanci LN; Pasqualucci L; Ascani S; Mencarelli A; Liso A; Pelicci PG; Falini B
Am J Pathol; 1996 Dec; 149(6):2023-35. PubMed ID: 8952536
[TBL] [Abstract][Full Text] [Related]
4. Expression of nucleolar protein p120 in human lung cancer: difference in histological types as a marker for proliferation.
Uchiyama B; Saijo Y; Kumano N; Abe T; Fujimura S; Ohkuda K; Handa M; Satoh K; Nukiwa T
Clin Cancer Res; 1997 Oct; 3(10):1873-7. PubMed ID: 9815576
[TBL] [Abstract][Full Text] [Related]
5. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
Tussié-Luna MI; Rozo L; Roy AL
Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
[TBL] [Abstract][Full Text] [Related]
6. Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies.
McNeil S; Javed A; Harrington KS; Lian JB; Stein JL; van Wijnen AJ; Stein GS
J Cell Biochem; 2000 Jul; 79(1):103-12. PubMed ID: 10906759
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues.
Chan JY; Chin W; Liew CT; Chang KS; Johnson PJ
Eur J Cancer; 1998 Jun; 34(7):1015-22. PubMed ID: 9849449
[TBL] [Abstract][Full Text] [Related]
8. A novel nuclear substructure, ND10: distribution in normal and neoplastic human tissues.
Cho Y; Lee I; Maul GG; Yu E
Int J Mol Med; 1998 Apr; 1(4):717-24. PubMed ID: 9852287
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-dependent alteration in NAC1 nuclear body dynamics and morphology.
Wu PH; Hung SH; Ren T; Shih IeM; Tseng Y
Phys Biol; 2011 Feb; 8(1):015005. PubMed ID: 21301057
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the nuclear structure in normal tissues and in carcinoma].
GRUNDMANN E; STEIN P
Beitr Pathol Anat; 1961; 125():54-76. PubMed ID: 13902442
[No Abstract] [Full Text] [Related]
11. PML Nuclear bodies: the cancer connection and beyond.
Abou-Ghali M; Lallemand-Breitenbach V
Nucleus; 2024 Dec; 15(1):2321265. PubMed ID: 38411156
[TBL] [Abstract][Full Text] [Related]
12. Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies.
Voon HPJ; Hii L; Garvie A; Udugama M; Krug B; Russo C; Chüeh AC; Daly RJ; Morey A; Bell TDM; Turner SJ; Rosenbluh J; Daniel P; Firestein R; Mann JR; Collas P; Jabado N; Wong LH
Genome Biol; 2023 Dec; 24(1):284. PubMed ID: 38066546
[TBL] [Abstract][Full Text] [Related]
13. LDL Affects the Immunomodulatory Response of Endothelial Cells by Modulation of the Promyelocytic Leukemia Protein (PML) Expression via PKC.
Roos K; Berkholz J
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108469
[TBL] [Abstract][Full Text] [Related]
14. Hepatocytes Deficient in Nuclear Envelope Protein Lamina-associated Polypeptide 1 are an Ideal Mammalian System to Study Intranuclear Lipid Droplets.
Östlund C; Hernandez-Ono A; Turk SJ; Dauer WT; Ginsberg HN; Worman HJ; Shin JY
J Lipid Res; 2022 Oct; 63(10):100277. PubMed ID: 36100089
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA.
Park R; Miller G
J Virol; 2018 Oct; 92(20):. PubMed ID: 30068640
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.
Medrano RFV; Hunger A; Mendonça SA; Barbuto JAM; Strauss BE
Oncotarget; 2017 Sep; 8(41):71249-71284. PubMed ID: 29050360
[TBL] [Abstract][Full Text] [Related]
17. Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape.
Landolfo S; De Andrea M; Dell'Oste V; Gugliesi F
World J Virol; 2016 Aug; 5(3):87-96. PubMed ID: 27563536
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic PML promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract][Full Text] [Related]
19. The function, regulation and therapeutic implications of the tumor suppressor protein, PML.
Guan D; Kao HY
Cell Biosci; 2015; 5():60. PubMed ID: 26539288
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.
Sahin U; Ferhi O; Jeanne M; Benhenda S; Berthier C; Jollivet F; Niwa-Kawakita M; Faklaris O; Setterblad N; de Thé H; Lallemand-Breitenbach V
J Cell Biol; 2014 Mar; 204(6):931-45. PubMed ID: 24637324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
